top of page

“Refined” COVID-19 Vaccine Program of Sanofi and GSK Launches Phase II Trial

#Sanofi and #GlaxoSmithKline have begun a new mid-stage study of a “refined” formulation of their adjuvanted recombinant protein-based #COVID19 candidate, with plans to advance to Phase III next quarter and reach the market by year’s end.

4 views0 comments


Post: Blog2_Post
bottom of page